HCR Wealth Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,466
Closed -$1.16M 193
2019
Q1
$1.16M Buy
9,466
+162
+2% +$14.2K 0.33% 60
2018
Q4
$596K Sell
9,304
-2,645
-22% -$195K 0.19% 90
2018
Q3
$960K Buy
11,949
+824
+7% +$72.8K 0.31% 75
2018
Q2
$893K Sell
11,125
-628
-5% -$52.1K 0.29% 79
2018
Q1
$1.05M Sell
11,753
-795
-6% -$76.3K 0.36% 68
2017
Q4
$1.1M Buy
12,548
+2,113
+20% +$238K 0.38% 61
2017
Q3
$1.52M Buy
10,435
+663
+7% +$90.3K 0.64% 38
2017
Q2
$1.2M Sell
9,772
-2,184
-18% -$268K 0.59% 40
2017
Q1
$801K Buy
11,956
+327
+3% +$39.1K 0.41% 60
2016
Q4
$767K Buy
+11,629
New +$1.3M 0.41% 59

Other funds holding CELG

HCR Wealth Advisors's CELG Position: Q2 2019 in Review

HCR Wealth Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 9,466 shares — an estimated $1.16M sold.

HCR Wealth Advisors first reported a position in CELG in Q4 2016 and held it in 10 quarters. The position peaked at $1.52M in Q3 2017. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • HCR Wealth Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • HCR Wealth Advisors sold 9,466 Celgene Corp shares in Q2 2019, an estimated $1.16M.
  • HCR Wealth Advisors first reported a position in Celgene Corp in Q4 2016 and held it in 10 quarters.
  • HCR Wealth Advisors's Celgene Corp position peaked at $1.52M in Q3 2017.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on HCR Wealth Advisors's 13F filing for Q2 2019, filed 25 Jul 2019.